Needham Reiterates Hold on Lululemon Athleticato Hold
Lululemon Athletica Analyst Ratings
"AI+" is the goose that lays golden eggs, with the collective frenzy of US software companies, SoundHound AI continues to rise by 16% before the market opens.
① In the US stock market, there are more and more leading stocks in the "AI+" sector, with "AI+ Voice" concept stocks rising nearly 530% this year and "AI+ Defense" concept stocks increasing over 318%... ② Several concept stocks have demonstrated profitable avenues for ai through unexpected earnings reports. ③ "The era of ai software has arrived." With the rapid increase in usage scenarios, analysts expect companies to enter the large-scale ai application phase starting in 2025.
Needham Initiates Coverage On Monster Beverage With Hold Rating
Monster Beverage Analyst Ratings
Biggest Stock Movers Friday: DOCU, ULTA, LULU, and More
Italy's IGenius Unveils Nvidia DGX AI Supercomputer With Grace Blackwell Chips
Be wary of the bubble in the US stock market! Bridgewater's chief investment officer unveils the value preservation "holy grail".
The CIO of Bridgewater stated that investors' allocation to stocks is more concentrated than ever, particularly in usa stocks.
Piper Sandler Maintains Overweight on Synopsys, Lowers Price Target to $655
Synopsys Analyst Ratings
TSLA Stock Sees Multiple Price Target Hikes Days After Long-Time Bear Turned Bullish
Should investors chase the rise or avoid risks? The tug-of-war of global investors in the U.S. stock market!
For fund managers, the imminent return of President Trump to the White House and lingering concerns about inflation give them reason to feel anxious, but the biggest risk may lie in their reliance on the USA stock market.
Express News | Pre-market trading: SoundHound AI continued to rise nearly 10%; many high-performing stocks increased, with Lululemon gaining over 9%.
Daily options tracking | A call option for Tesla earned up to 4 times! The stock price has reached a two-year high; Are meme stocks making a comeback? Gamestop's options volume surged 3.8 times, with multiple end date options making over 2 times profit.
nvidia saw two large transactions of over 10 million dollars in call options yesterday, totaling more than 57 million dollars.
The FDA Has Accepted And Granted Priority Review To AstraZeneca's Supplemental Biologics License Application For Imfinzi (Durvalumab) For Muscle-invasive Bladder Cancer. The Prescription Drug User Fee Act Date Is Anticipated During The Second Quarter...
Jensen Huang invested in the company of Vietnam's richest person, nvidia has made another move in medical AI.
①Huang Renxun announced that nvidia will acquire VinBrain, a medical AI technology company under Vingroup in Vietnam; ②Pan Riwang, Chairman of Vingroup Group, ranks 458th on the Forbes Global Billionaires List with a wealth of 5.9 billion USD. ③Hurun's latest report points out that new forces in the medical AI direction now account for over 20% of the medical industry.
The leadership change at intel: Can the new CEO break the technological impasse?
Investors should avoid buying Intel stocks until the new management team demonstrates the ability to balance Intel's short-term and long-term priorities.
Elon Musk's XAI Raises $6B For The 2nd Time This Year As It Looks To Take The Challenge To OpenAI, Google And Jeff Bezos-Backed Anthropic
Dr. Rubin, the doomsday doctor: Trump will lead the usa into stagflation.
Roubini believes that at least two policies will increase long-term inflation risks: one is to strictly limit immigration or even to carry out large-scale deportations of immigrants, and the second is tax reduction policies that lead to a vicious expansion of fiscal deficits, further disrupting and weakening the position of the dollar.
Reported Earlier, Daiichi Sankyo And AstraZeneca's Datopotamab Deruxtecan Shows Meaningful Clinical Activity In Advanced EGFR-Mutated NSCLC In TROPION-Lung05 And TROPION-Lung01 Analysis